DrugPatentWatch Database Preview
Sagent Pharms Company Profile
What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?
SAGENT PHARMS has sixty-six approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Summary for Sagent Pharms
| US Patents: | 0 |
| Tradenames: | 53 |
| Ingredients: | 51 |
| NDAs: | 66 |
Drugs and US Patents for Sagent Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms | HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 200742-001 | Sep 2, 2011 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 207107-002 | Jun 8, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 091684-001 | Oct 31, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 090584-002 | Aug 28, 2012 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
